NEW YORK (Reuters) - Drugmakers are building safety "switches" that can be used to turn off powerful cancer therapies known as CAR T cells when they cause life-threatening inflammation or attack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback